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Abstract 
Phototherapy is the most commonly 
used therapeutic intervention for the 
treatment of hyperbilirubinemia (jaundice). 
Fiberoptic, fluorescent tubes, halogen bulb 
and also LEDs are among regular light 
sources used for phototherapy. 
Phototherapy treatments using florescence 
light which is usually used in hospitals 
require continuous uninterrupted treatment 
period and need infants to be uncovered 
and only wear eye patches. These 
conditions are not preferable for infants as 
they tend to get cold easily and feel 
uncomfortable. It is also not encouraging for 
breastfeeding mothers as the treatment 
needs to be continuous. The rapid 
development of high intensity light-emitting 
diodes (LEDs) makes feasible the use of 
LEDs, among other light sources for use in 
the design of a garment phototherapy 
device. The paper describes the design of a 
phototherapy vest for infants, using 
ultraviolet (UV) LEDs and Arduino 
microcontroller for use in reducing bilirubin 
level in infants with jaundice. The garment 
phototherapy device is comfortable to wear 
and infants are no longer required to wear 
eye patches.  The proposed device is 
portable, uses a small power supply and 
easy to be operated anywhere.  
 
Introduction 
Hyperbilirubinemia or also known as 
jaundice is a disease that is common in 
newborn infants. It is the yellowing of the 
skin and other tissues due to the increase of 
bilirubin level in an infant’s body. Almost 
60% to 70% of infants at the age of 35 
weeks to 38 weeks, have a greater risk of 
encountering jaundice which can either 
happen in premature or full-term infants [1]. 
Jaundice can be divided into physiologic 
and pathologic. Physiologic is 
compassionate and common in normal 
infant, whereas pathologic jaundice despite 
bile pigments in the brain stem, causing 
brain damage known as kerticterus. 
Jaundice happens due to several factors, 
which include blood incompatibility between 
the mother and infant (both have different 
blood rhesus), lack of enzyme which causes 
unstable red blood cells when exposed to 
certain substances, virus infections in infant 
such as rubella, herpes simplex and also 
syphilis, and immature liver condition during 
breakdown of red blood cells [2]. All of these 
factors may lead to increase in bilirubin level 
inside an infant’s body and it can cause 
death if not treated immediately.  
 
Conventionally, jaundice is treated by 
exposing the infant to sunlight, preferably in 
the early morning or late evening. It is 
important not to expose the infant directly to 
sunlight as it can cause burns to the infant’s 
sensitive skin. The infant can be placed in a 
room that receives sufficient sunlight and 
exposed for thirty (30) minutes. It is 
essential to get the infant to be comfortable 
during the treatment. The treatment is 
repeated several times in a day which 
usually should be able to decrease the 
infant’s bilirubin level within a week.  
 
Nowadays, the most common medical 
treatment to cure jaundice is through 
phototherapy. Infants will be exposed under 
blue light for a certain period of time until 
their bilirubin level decreases to a level that 
is safe for the infant. By exposing infants 
under UV light, bilirubin will be discrete from 
the infants’ bodies through their feces and 
urine which changes the bilirubin to its 
break down compound. Lumirubin and 
photobilirubin are compounds produced 
from bilirubin by exposing it to a certain 
wavelength of light as both are isomers of 
bilirubin that have been rearranged from the 
same atoms. In phototherapy, when light 
penetrates the skin, bilirubin will be 
converted into its isomers (photobilirubin 
and lumirubin) and removed from the body 
without the involvement of the liver [3].  
 
Over the years, there have been 
significant improvements in the medical 
technology field, similarly in phototherapy 
treatments. Hospitals have been equipped 
with various types of phototherapy devices 
to treat patients with jaundice, particularly 
newborns. The use of these devices are 
proven to be able to treat jaundice more 
effectively while reducing the duration of 
treatment with less risk to the infants [4] . 
The light source for these phototherapy 
devices ranges from fluorescent bulbs, 
halogen bulbs, and also fiberoptics [5]. The 
latest phototherapy devices now use the 
technology of light emitting diode (LED) 
which has proven to be able to reduce 
bilirubin level faster compared to other 
phototherapy device [4].  
 
Materials & Method  
 
There are several factors that need to 
be considered to determine the LEDs’ 
arrangement. These include the effective 
light field, light wavelength and also 
maximum power dissipation of the UV 
LEDs. The SI unit used is mW/cm2. Below 
are the calculations that were used to 
determine the position of the LEDs on the 
garment and the distance between each 
LED. 
 
                               
                          
 
                               
                               
                                
                          
 
           
 
                    
                      
              
 
 
                        
 
    
     
 
      
 
 
                                                   
    
The calculated irradiance value obtained 
is higher than the minimum irradiance 
required by The America Academy of 
Paediatrics (AAP) to treat jaundice. 
Referring to the AAP guidelines, as shown 
in Figure 5, intensive phototherapy is 
defined as the use of blue light delivered at 
30µW/cm2/nm or higher to the greatest 
exposed body surface area (BSA) as 
possible [2].   
 
 
Figure 5: AAP Guideline for neonatal 
jaundice  
 
Figure 6 illustrates the component 
layout and block diagram of the automatic 
phototherapy vest. The system is controlled 
by the Arduino Uno microcontroller, an open 
source electronics prototyping platform 
which is commonly used in designing 
interactive devices. All UV LEDs are sewn 
on the garment using conductive threads 
which are able to carry current for power 
and signal. The push button is used to set 
the duration of treatment which is only 
enabled when the infant’s body temperature 
is in the normal range. The timing circuit 
and the UV LEDs will be switched on once 
the period selection is set and switched off 
depending on the duration chosen. The 
device will automatically turn off and trigger 
the buzzer once the treatment period is 
complete. The temperature detector sensor 
continuously measures the infant’s body 
temperature throughout the treatment 
period. All temperature readings and set 
time for the treatment will be displayed on 
the LCD.  
.  
 
 
(a) Component layout 
 
(b) Block diagram 
 
Figure 6: Automatic Phototherapy Vest 
 
The design of the APV consists of 
two (2) main parts, the hardware part and 
software part. 
 
Software  
 
 The Arduino software (using C/C++ 
programming language) is used to 
program the Arduino Uno 
microcontroller, which acts as a brain for 
the system.  
 The temperature output from the LilyPad 
Arduino temperature sensor is used to 
monitor infant’s body temperature by 
comparing the measured temperature 
with the set temperature (temperature 
for infant under normal condition = 36-
37 Celsius). 
 The program also controls the ON/OFF 
switching duration of the UV LEDs and 
triggers the buzzer once treatment is 
complete.  
 
Hardware 
 
The Ardunio Uno microcontroller board 
used in the APV is based on the 
ATmega328 which has 14 digital 
input/output pins. The component layout of 
the circuit designed for the APV consists of 
five (5) major parts which includes the: 
 
• Temperature Sensor Circuit 
 The LM35 sensor is used to detect the 
infant’s temperature level with a scale 
factor of 10mV/°C. 
• Liquid Crystal Display (LCD)  
 The LCD displays the current infant’s 
body temperature level which is 
received from the Lilypad Arduino 
temperature sensor. 
• Option Push Buttons 
 The APV consists of three push buttons 
which includes the + (increase duration), 
- (decrease duration) and START (start 
treatment) button. These push buttons 
are used to set the treatment duration 
and also to start the treatment.  
• UV LEDs  
 This is the main part of the device. The 
UV LEDs will emit UV light which will 
help to reduce the bilirubin level in the 
infant’s body. 
• Buzzer  
 The buzzer will trigger when the 
treatment is complete to alert guardian 
to attend to their babies.  
 
Fig. 4 show the flow chart for this 
device, it explain how the Arduino software 
control the whole process in this device. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 Flow chart for APV 
Results and Discussion 
The controller (Arduino Uno) is able to 
control the switching of the UV LEDs.  Each 
UV LED of the vest is able to emit 51.28 
µW/cm2/nm (effective light field for each 
LED is 4cm2).   
 
Figure 7 illustrates the device when it is 
in the switched off set up. When the APV is 
on it will greet the user with a welcome note 
(Figure 9 (a)) and display the current 
infant’s body temperature (Figure 9 (b)). 
The device will only enable user to set the 
duration of treatment if the detected infant’s 
body temperature is in the range of the set 
temperature which is between 36°C -37°C. 
To start the treatment, a user needs to 
choose the appropriate duration of 
treatment (Figure 9 (c)). Once the duration 
is set, the user needs to press the ON push 
button and the treatment will start 
automatically. All the UV LEDs will be 
switched on for the desired duration, as 
shown in Figure 8 and Figure 9(d). The 
temperature sensor will measure the infants’ 
body temperature in every 1 second and will 
be displayed on the LCD. Once the 
treatment is complete, the buzzer will trigger 
to alarm the user and a complete 
notification message will be displayed on 
the LCD (Figure 9 (f)). 
 
 
Figure 7: APV Full Set Up (LED switched 
off)    
 
 
Figure 8: APV Full Set Up (Treatment on 
going, LED switched on) 
 
Throughout the operation, user will be 
notified with a welcoming note, current 
infant’s temperature, duration of treatment, 
complete treatment message and 
Sense body temperature 
 
Set treatment duration 
Compare with 
Set temperature 
36°C < T > 37°C  
 
No 
Yes 
LED ON 
Compare with 
treatment duration. 
 
No 
Trigger buzzer 
Yes 
LED OFF 
Automatically off 
 
notification if the infant’s body temperatures 
exceeds the set temperature (Figure 4.8 
(e)). Figure 4.8 illustrates the operation flow 
of the APV. 
 
 
a) Welcome note 
 
b) Current 
temperature 
 
c) Selected time 
 
d) LED turn ON 
 
e) Temperature 
display 
 
f) Treatment 
complete 
 
Figure 9: Complete operational flow of APV 
 
 
7. Conclusion 
The Automated Phototherapy Vest 
(APV) is designed to help in reducing 
infants’ bilirubin level by exposing infants 
under the UV LED lights. The emitting UV 
LEDs from the phototherapy vest is able to 
emit the desired power which will help in 
reducing bilirubin level in an infants’ body. 
The device is also able to monitor the 
infants’ body temperature and automatically 
turns OFF when it detects that the 
temperature exceeds the limit temperature 
set in the device. The required power supply 
is small and the vest is easy to wear and 
comfortable to be operated at the hospital or 
even at home. The battery for this device 
can be easily replaced and it only requires a 
low cost to the user. By using the APV, 
mothers no longer have to leave their 
babies at the paediatric wards and they are 
able to monitor their own baby’s condition. 
Mothers can also breastfeed even during 
the treatment. The device will automatically 
turn OFF once treatment is complete and 
this prevents, the infants from getting an 
over exposure of the UV light even when 
the user/guardian is unaware of it. The 
buzzer will also acts as an alarm to remind 
the user/guardian that the treatment period 
has end and for them to attend to their 
babies. 
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